210 related articles for article (PubMed ID: 24764159)
1. Immunogenicity and antigenicity of Plasmodium vivax merozoite surface protein 10.
Cheng Y; Wang B; Sattabongkot J; Lim CS; Tsuboi T; Han ET
Parasitol Res; 2014 Jul; 113(7):2559-68. PubMed ID: 24764159
[TBL] [Abstract][Full Text] [Related]
2. Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3.
Bitencourt AR; Vicentin EC; Jimenez MC; Ricci R; Leite JA; Costa FT; Ferreira LC; Russell B; Nosten F; Rénia L; Galinski MR; Barnwell JW; Rodrigues MM; Soares IS
PLoS One; 2013; 8(2):e56061. PubMed ID: 23457498
[TBL] [Abstract][Full Text] [Related]
3. Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7).
Cheng CW; Jongwutiwes S; Putaporntip C; Jackson AP
Malar J; 2019 Jun; 18(1):197. PubMed ID: 31196098
[TBL] [Abstract][Full Text] [Related]
4. Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit.
Valderrama-Aguirre A; Quintero G; Gómez A; Castellanos A; Pérez Y; Méndez F; Arévalo-Herrera M; Herrera S
Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):16-24. PubMed ID: 16291762
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
[TBL] [Abstract][Full Text] [Related]
6. Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1₁₉ and PvMSP-3α₃₅₉₋₇₉₈ and their relationship with hematological features in malaria patients from the Brazilian Amazon.
Mourão LC; Morais CG; Bueno LL; Jimenez MC; Soares IS; Fontes CJ; Guimarães Lacerda MV; Xavier MS; Barnwell JW; Galinski MR; Braga EM
Microbes Infect; 2012 Aug; 14(9):730-9. PubMed ID: 22445906
[TBL] [Abstract][Full Text] [Related]
7. Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli.
Dutta S; Ware LA; Barbosa A; Ockenhouse CF; Lanar DE
Infect Immun; 2001 Sep; 69(9):5464-70. PubMed ID: 11500418
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
[TBL] [Abstract][Full Text] [Related]
9. Murine immune responses to a Plasmodium vivax-derived chimeric recombinant protein expressed in Brassica napus.
Lee C; Kim HH; Choi KM; Chung KW; Choi YK; Jang MJ; Kim TS; Chung NJ; Rhie HG; Lee HS; Sohn Y; Kim H; Lee SJ; Lee HW
Malar J; 2011 Apr; 10():106. PubMed ID: 21529346
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of Pv50, a novel Plasmodium vivax merozoite surface protein.
Cheng Y; Wang B; Lu F; Ahmed MA; Han JH; Na SH; Ha KS; Park WS; Hong SH; Han ET
Parasit Vectors; 2019 Apr; 12(1):176. PubMed ID: 30999945
[TBL] [Abstract][Full Text] [Related]
11. Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli.
Sachdeva S; Ahmad G; Malhotra P; Mukherjee P; Chauhan VS
Infect Immun; 2004 Oct; 72(10):5775-82. PubMed ID: 15385477
[TBL] [Abstract][Full Text] [Related]
12. A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions.
Hostetler JB; Sharma S; Bartholdson SJ; Wright GJ; Fairhurst RM; Rayner JC
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004264. PubMed ID: 26701602
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a plasmid DNA vaccine encoding 42kDa fragment of Plasmodium vivax merozoite surface protein-1.
Sheikh IH; Kaushal DC; Chandra D; Kaushal NA
Acta Trop; 2016 Oct; 162():66-74. PubMed ID: 27311385
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II.
Ntumngia FB; Schloegel J; McHenry AM; Barnes SJ; George MT; Kennedy S; Adams JH
Vaccine; 2013 Sep; 31(40):4382-8. PubMed ID: 23916294
[TBL] [Abstract][Full Text] [Related]
15. Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.
Mehrizi AA; Zakeri S; Rafati S; Salmanian AH; Djadid ND
Parasite Immunol; 2011 Nov; 33(11):594-608. PubMed ID: 21883290
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel merozoite surface protein of Plasmodium vivax, Pv41.
Cheng Y; Lu F; Tsuboi T; Han ET
Acta Trop; 2013 Jun; 126(3):222-8. PubMed ID: 23499861
[TBL] [Abstract][Full Text] [Related]
17. Antigenicity studies in humans and immunogenicity studies in mice: an MSP1P subdomain as a candidate for malaria vaccine development.
Cheng Y; Shin EH; Lu F; Wang B; Choe J; Tsuboi T; Han ET
Microbes Infect; 2014 May; 16(5):419-28. PubMed ID: 24560875
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli.
Oliveira-Ferreira J; Vargas-Serrato E; Barnwell JW; Moreno A; Galinski MR
Vaccine; 2004 May; 22(15-16):2023-30. PubMed ID: 15121316
[TBL] [Abstract][Full Text] [Related]
19. Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeast.
Vicentin EC; Françoso KS; Rocha MV; Iourtov D; Dos Santos FL; Kubrusly FS; Sakauchi MA; Raw I; Nosten F; Rénia L; Rodrigues MM; Russell B; Soares IS
Infect Immun; 2014 Mar; 82(3):1296-307. PubMed ID: 24379279
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.
Kale S; Yadav CP; Rao PN; Shalini S; Eapen A; Srivasatava HC; Sharma SK; Pande V; Carlton JM; Singh OP; Mallick PK
Malar J; 2019 Dec; 18(1):425. PubMed ID: 31842894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
